アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
Fluorescent western blotting involves secondary antibodies being conjugated to fluorescent dyes and therefore circumvents the need for film and chemiluminescence.
Other advantages of fluorescent western blotting include:
Quality and performance of labeled secondary antibodies is crucial for fluorescent western blotting, the reagents must be optimized for signal:noise ratios. Furthermore, if the number of fluorescent molecules per secondary (F:P ratio) is too low the signal will be weak; if the F:P is too high, the signal will also be weak due to the inactivation of the fluorescent dye as a result of FRET.
We have generated a range of Alexa Fluor® secondary antibodies which have been manufactured and validated for fluorescent western blotting in our laboratories - ensuring quality and performance. The F:P ratios have been optimized to overcome problems highlighted above; furthermore we have developed a broad portfolio of Alexa Fluor® labeled secondary antibodies to facilitate multi-color fluorescent western blotting.
Figure legend - multi-color analysis using our Alexa Fluor® 680 (red) and 790 (green) secondary antibodies. Decreasing amounts of HeLa extract (lane 1=25µg, lane 2=20µg, lane 3=15µg, lane 4=10µg and lane 5=7µg) demonstrate staining of GAPDH (primary antibody ab83956 + anti-chicken Alexa Fluor® 790 - green, ab175787) and alpha tubulin (primary antibody 18251 + anti-rabbit Alexa Fluor® 680 - red, ab 175773).
Our range of Alexa Fluor® conjugated secondaries optimized for fluorescent western blotting.
|Alexa Fluor®||Absorption Max (nm)||Emission Max (nm)||Extinction Coefficient|
Alexa Fluor® is a registered trademark of Life Technologies. Alexa Fluor® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.